Skip to main content

Table 3 Univariate analysis (binary logistic regression) for prescribing monotherapy versus combination therapy

From: Conformance to schizophrenia treatment guidelines in North West-Bank, Palestine: focus on antipsychotic dosing and polytherapy

Variable

Reference category

β

p-value

Odds ratio with 95% CI

Gender

Male

0.43

0.14

1.5 (0.88 – 2.7)

Age

Continuous variable

0.008

0.5

1.0 (1.0-1.03)

Education

School education

0.338

0.4

1.4 (0.7-2.8)

Marital status

Single

−0.2

0.4

0.8 (0.5-1.3)

Smoking

Not smoking

0.45

0.04

1.7 (1.02-2.9)

Occupation

Not working

0.055

0.9

1.1 (0.5-2.2)

Waist circumferences

Normal WC

−0.16

0.5

0.9 (0.52-1.4)

Duration of psychiatric illness

< 10 years

0.7

0.01

2 (1.2-3.4)

Number of hospitalization

< 2

1.02

0.001

2.8 (1.5-5.1)

Family history of DM

No family history

−0.16

0.53

0.9 (0.42-1.4)

Depot

No depot

2.0

< 0.001

7.4 (4.2-12.9)

Anticholinergic

No anticholinergics

1.9

<0.001

6.7 (3.5-12.8)

SGA

No SGA

−0.4

0.2

0.7 (0.4-1.2)

CPZeq

Continuous variable

−5.5

<0.001

1.01 (1.0 – 1.01)

  1. Abbreviations: CI confidence interval, β coefficient of predictor variables, DM diabetes mellitus, SGA Second Generation Antipsychotic, CPZeq Chlorpromazine Dose Equivalencies.